This is the 2nd component of the biotech firm’s stage Ib research study with the medicine dapiglutide, which is based upon the GLP-1 and GLP-2 representatives.
发布者:BY MARKETWIRE,转转请注明出处:https://robotalks.cn/zealand-pharma-presents-strong-weight-loss-data-with-drug-candidate/